The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.
12. Retinopathy, Neuropathy, and Foot Care: Standards of Care in Diabetes—2024
Open accessAbstract
The American Diabetes Association (ADA) “Standards of Care in Diabetes” includes the ADA’s current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, an interprofessional expert committee, are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA’s clinical practice recommendations and a full list of Professional Practice Committee members, please refer to Introduction and Methodology. Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Global prevalence and major risk factors of diabetic retinopathy
Yau, J. W. Y., Rogers, S. L., Kawasaki, R., Lamoureux, E. L., Kowalski, J. W., Bek, T., Chen, S.-J., Dekker, J. M., Fletcher, A., Grauslund, J., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1909 · Cited by 4,985
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602 · cited 4×
“See the American Diabetes Association position statement “ Diabetic Neuropathy ” for more details (46).”
InfluentialGlobal Vascular Guidelines on the management of chronic limb-threatening ischemia.
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2019.02.016 · Cited by 2,015
Abràmoff, M. D., Lavin, P. T., Birch, M., Shah, N., & Folk, J. C. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0040-6 · Cited by 1,638
Global vascular guidelines on the management of chronic limb-threatening ischemia
Conte, M. S., Bradbury, A. W., Kolh, P., White, J. V., Dick, F., Fitridge, R., Mills, J. L., Ricco, J.-B., Suresh, K. R., Murad, M. H., et al. (2019) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2019.05.006 · Cited by 1,582
Ismail-Beigi, F., Craven, T., Banerji, M. A., Basile, J., Calles, J., Cohen, R. M., Cuddihy, R., Cushman, W. C., Genuth, S., Grimm, R. H., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60576-4 · Cited by 1,428
Effects of medical therapies on retinopathy progression in type 2 diabetes
The ACCORD Study Group and ACCORD Eye Study Group (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001288 · Cited by 1,311
Clinical Guideline: Management of Gastroparesis
Camilleri, M., Parkman, H. P., Shafi, M. A., Abell, T. L., & Gerson, L. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.373 · Cited by 1,149
Stratton, I. M., Kohner, E. M., Aldington, S. J., Turner, R. C., Holman, R. R., Manley, S. E., & Matthews, D. R. (2001) · Diabetologia · doi:10.1007/s001250051594 · Cited by 1,019
Peripheral arterial disease in people with diabetes
American Diabetes Association (2003) · Diabetes Care · doi:10.2337/diacare.26.12.3333 · Cited by 953
Boulton (2008) · doi:10.2337/dc08-9021 · Cited by 928
Pham, H., Armstrong, D. G., Harvey, C., Harkless, L. B., Giurini, J. M., & Veves, A. (2000) · Diabetes Care · doi:10.2337/diacare.23.5.606 · Cited by 654
Self-citationHingorani, A., LaMuraglia, G. M., Henke, P., Meissner, M. H., Loretz, L., Zinszer, K. M., Driver, V. R., Frykberg, R., Carman, T. L., Marston, W., et al. (2016) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2015.10.003 · Cited by 641
Pop-Busui, R., Evans, G. W., Gerstein, H. C., Fonseca, V., Fleg, J. L., Hoogwerf, B. J., Genuth, S., Grimm, R. H., Corson, M. A., Prineas, R., et al. (2010) · Diabetes Care · doi:10.2337/dc10-0125 · Cited by 540
Martin, C. L., Albers, J. W., Pop-Busui, R., & for the DCCT/EDIC Research Group (2014) · Diabetes Care · doi:10.2337/dc13-2114 · Cited by 499
Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes.
Löndahl, M., Katzman, P., Nilsson, A., & Hammarlund, C. (2010) · Diabetes Care · doi:10.2337/dc09-1754 · Cited by 441
Diabetes Control and Complications Trial Research Group (2000) · Diabetes Care · doi:10.2337/diacare.23.8.1084 · Cited by 385
Pop-Busui, R., Low, P. A., Waberski, B. H., Martin, C. L., Albers, J. W., Feldman, E. L., Sommer, C., Cleary, P. A., Lachin, J. M., & Herman, W. H. (2009) · Circulation · doi:10.1161/circulationaha.108.837369 · Cited by 310
Not Available, N. A. (1998) · Diabetologia · doi:10.1007/s001250050924 · Cited by 308
Andersen, S. T., Witte, D. R., Dalsgaard, E.-M., Andersen, H., Nawroth, P., Fleming, T., Jensen, T. M., Finnerup, N. B., Jensen, T. S., Lauritzen, T., et al. (2018) · Diabetes Care · doi:10.2337/dc17-2062 · Cited by 248
Olausson, E. A., Störsrud, S., Grundin, H., Isaksson, M., Attvall, S., & Simrén, M. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.453 · Cited by 217
Dietary Intake and Nutritional Deficiencies in Patients With Diabetic or Idiopathic Gastroparesis
Parkman, H. P., Yates, K. P., Hasler, W. L., Nguyan, L., Pasricha, P. J., Snape, W. J., Farrugia, G., Calles, J., Koch, K. L., Abell, T. L., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.045 · Cited by 198
Pop-Busui, R., Lu, J., Brooks, M. M., Albert, S., Althouse, A. D., Escobedo, J., Green, J., Palumbo, P., Perkins, B. A., Whitehouse, F., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0012 · Cited by 167
Gunderson, E. P., Lewis, C. E., Tsai, A.-L., Chiang, V., Carnethon, M., Quesenberry, C. P., & Sidney, S. (2007) · Diabetes · doi:10.2337/db07-1024 · Cited by 164
Bethel, M. A., Diaz, R., Castellana, N., Bhattacharya, I., Gerstein, H. C., & Lakshmanan, M. C. (2021) · Diabetes Care · doi:10.2337/dc20-1815 · Cited by 151
Frequency of evidence-based screening for retinopathy in type 1 diabetes
The DCCT/EDIC Research Group (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1612836 · Cited by 141
Screening for Presence or Absence of Diabetic Retinopathy: A Meta-analysis
Bragge, P. (2011) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2010.319 · Cited by 134
Agardh, E., & Tababat-Khani, P. (2011) · Diabetes Care · doi:10.2337/dc10-2308 · Cited by 113
A Systematic Review of the Efficacy of Domperidone for the Treatment of Diabetic Gastroparesis
Sugumar, A., Singh, A., & Pasricha, P. J. (2008) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2008.02.065 · Cited by 102
Association Between Cardiovascular Autonomic Neuropathy and Left Ventricular Dysfunction
Pop-Busui, R., Cleary, P. A., Braffett, B. H., Martin, C. L., Herman, W. H., Low, P. A., Lima, J. A. C., & Bluemke, D. A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.028 · Cited by 88
New Evidence-Based Therapies for Complex Diabetic Foot Wounds
Boulton, A., Armstrong, D., Londahl, M., Frykberg, R., Game, F., Edmonds, M., Orgill, D., Kramer, K., Gurtner, G., Januszyk, M., et al. (2022) · ADA Clinical Compendia · doi:10.2337/db2022-02 · Cited by 66
Tang, Y., Shah, H., Bueno Junior, C. R., Sun, X., Mitri, J., Sambataro, M., Sambado, L., Gerstein, H. C., Fonseca, V., Doria, A., et al. (2021) · Diabetes Care · doi:10.2337/dc20-1842 · Cited by 60
Carter, M. J., Frykberg, R. G., Oropallo, A., Sen, C. K., Armstrong, D. G., Nair, H. K. R., & Serena, T. E. (2023) · Advances in Wound Care · doi:10.1089/wound.2022.0041 · Cited by 55
Nutritional management of gastroparesis in people with diabetes
Parrish, C. R., & Pastors, J. G. (2007) · Diabetes Spectrum · doi:10.2337/diaspect.20.4.231 · Cited by 27
Research works printed but not linked: 75
- Solomon, 2017, Diabetic retinopathy: a position statement by the American Diabetes Association, Diabetes Care, 40, 412, 10.2337/dc16-2641 · DOI · Paper page
- Nathan, 1993, The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus, N Engl J Med, 329, 977, 10.1056/NEJM199309303291401 · DOI · Paper page
- Estacio, 1998, Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM, Am J Kidney Dis, 31, 947, 10.1053/ajkd.1998.v31.pm9631838 · DOI
- Eid, 2019, New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism, Diabetologia, 62, 1539, 10.1007/s00125-019-4959-1 · DOI · Paper page
- UK Prospective Diabetes Study (UKPDS) Group, 1998, Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33), Lancet, 352, 837, 10.1016/S0140-6736(98)07019-6 · DOI · Paper page
- Gubitosi-Klug, 2016, Effects of prior intensive insulin therapy and risk factors on patient-reported visual function outcomes in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) cohort, JAMA Ophthalmol, 134, 137, 10.1001/jamaophthalmol.2015.4606 · DOI
- Aiello, 2015, Intensive diabetes therapy and ocular surgery in type 1 diabetes, N Engl J Med, 372, 1722, 10.1056/NEJMoa1409463 · DOI
- Dabelea, 2017, Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood, JAMA, 317, 825, 10.1001/jama.2017.0686 · DOI · Paper page
- Silva, 2016, Identification of diabetic retinopathy and ungradable image rate with ultrawide field imaging in a national teleophthalmology program, Ophthalmology, 123, 1360, 10.1016/j.ophtha.2016.01.043 · DOI
- Walton, 2016, Evaluation of automated teleretinal screening program for diabetic retinopathy, JAMA Ophthalmol, 134, 204, 10.1001/jamaophthalmol.2015.5083 · DOI
- Daskivich, 2017, Implementation and evaluation of a large-scale teleretinal diabetic retinopathy screening program in the Los Angeles County Department of Health Services, JAMA Intern Med, 177, 642, 10.1001/jamainternmed.2017.0204 · DOI
- Sim, 2016, The evolution of teleophthalmology programs in the United Kingdom: beyond diabetic retinopathy screening, J Diabetes Sci Technol, 10, 308, 10.1177/1932296816629983 · DOI
- Widyaputri, 2022, Global estimates of diabetic retinopathy prevalence and progression in pregnant women with preexisting diabetes: a systematic review and meta-analysis, JAMA Ophthalmol, 140, 486, 10.1001/jamaophthalmol.2022.0050 · DOI
- The Diabetic Retinopathy Study Research Group, 1976, Preliminary report on effects of photocoagulation therapy, Am J Ophthalmol, 81, 383, 10.1016/0002-9394(76)90292-0 · DOI · Paper page
- Early Treatment Diabetic Retinopathy Study research group, 1985, Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1, Arch Ophthalmol, 103, 1796, 10.1001/archopht.1985.01050120030015 · DOI · Paper page
- Gross, 2015, Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: a randomized clinical trial, JAMA, 314, 2137, 10.1001/jama.2015.15217 · DOI · Paper page
- Sivaprasad, 2017, Clinical efficacy of intravitreal aflibercept versus panretinal photocoagulation for best corrected visual acuity in patients with proliferative diabetic retinopathy at 52 weeks (CLARITY): a multicentre, single-blinded, randomised, controlled, phase 2b, non-inferiority trial, Lancet, 389, 2193, 10.1016/S0140-6736(17)31193-5 · DOI · Paper page
- Maturi, 2021, Effect of intravitreous anti-vascular endothelial growth factor vs sham treatment for prevention of vision-threatening complications of diabetic retinopathy: the Protocol W randomized clinical trial, JAMA Ophthalmol, 139, 701, 10.1001/jamaophthalmol.2021.0606 · DOI
- Elman, 2011, Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema, Ophthalmology, 118, 609, 10.1016/j.ophtha.2010.12.033 · DOI · Paper page
- Mitchell, 2011, The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema, Ophthalmology, 118, 615, 10.1016/j.ophtha.2011.01.031 · DOI · Paper page
- Wells, 2015, Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema, N Engl J Med, 372, 1193, 10.1056/NEJMoa1414264 · DOI · Paper page
- Baker, 2019, Effect of initial management with aflibercept vs laser photocoagulation vs observation on vision loss among patients with diabetic macular edema involving the center of the macula and good visual acuity: a randomized clinical trial, JAMA, 321, 1880, 10.1001/jama.2019.5790 · DOI · Paper page
- Chew, 2014, The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) eye study, Ophthalmology, 121, 2443, 10.1016/j.ophtha.2014.07.019 · DOI · Paper page
- Shi, 2018, Effects of lipid-lowering agents on diabetic retinopathy: a meta-analysis and systematic review, Int J Ophthalmol, 11, 287
- Mazhar, 2011, Severity of diabetic retinopathy and health-related quality of life: the Los Angeles Latino Eye Study, Ophthalmology, 118, 649, 10.1016/j.ophtha.2010.08.003 · DOI
- Ang, 2014, Glucose control and diabetic neuropathy: lessons from recent large clinical trials, Curr Diab Rep, 14, 528, 10.1007/s11892-014-0528-7 · DOI · Paper page
- Bashir, 2021, Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications, Diabetes Metab Syndr, 15, 102241, 10.1016/j.dsx.2021.102241 · DOI
- Look AHEAD Research Group, 2017, Effects of a long-term lifestyle modification programme on peripheral neuropathy in overweight or obese adults with type 2 diabetes: the Look AHEAD study, Diabetologia, 60, 980, 10.1007/s00125-017-4253-z · DOI
- Callaghan, 2021, Dietary weight loss in people with severe obesity stabilizes neuropathy and improves symptomatology, Obesity (Silver Spring), 29, 2108, 10.1002/oby.23246 · DOI
- Freeman, 2009, Not all neuropathy in diabetes is of diabetic etiology: differential diagnosis of diabetic neuropathy, Curr Diab Rep, 9, 423, 10.1007/s11892-009-0069-7 · DOI
- Smith, 2014, The diagnostic utility of Sudoscan for distal symmetric peripheral neuropathy, J Diabetes Complications, 28, 511, 10.1016/j.jdiacomp.2014.02.013 · DOI
- Diabetes Control and Complications Trial (DCCT) Research Group, 1995, Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial, Ann Neurol, 38, 869, 10.1002/ana.410380607 · DOI · Paper page
- Albers, 2010, Effect of prior intensive insulin treatment during the Diabetes Control and Complications Trial (DCCT) on peripheral neuropathy in type 1 diabetes during the Epidemiology of Diabetes Interventions and Complications (EDIC) Study, Diabetes Care, 33, 1090, 10.2337/dc09-1941 · DOI · Paper page
- Callaghan, 2012, Enhanced glucose control for preventing and treating diabetic neuropathy, Cochrane Database Syst Rev, 6, CD007543
- Callaghan, 2016, Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status, Diabetes Care, 39, 801, 10.2337/dc16-0081 · DOI · Paper page
- Afshinnia, 2022, Serum lipidomic determinants of human diabetic neuropathy in type 2 diabetes, Ann Clin Transl Neurol, 9, 1392, 10.1002/acn3.51639 · DOI
- Lu, 2020, Prevalence and risk factors for diabetic peripheral neuropathy in type 2 diabetic patients from 14 countries: estimates of the INTERPRET-DD study, Front Public Health, 8, 534372, 10.3389/fpubh.2020.534372 · DOI
- Sadosky, 2013, Burden of illness associated with painful diabetic peripheral neuropathy among adults seeking treatment in the US: results from a retrospective chart review and cross-sectional survey, Diabetes Metab Syndr Obes, 6, 79, 10.2147/DMSO.S37415 · DOI · Paper page
- Waldfogel, 2017, Pharmacotherapy for diabetic peripheral neuropathy pain and quality of life: a systematic review, Neurology, 88, 1958, 10.1212/WNL.0000000000003882 · DOI · Paper page
- Price, 2022, Oral and topical treatment of painful diabetic polyneuropathy: practice guideline update summary: report of the AAN Guideline Subcommittee, Neurology, 98, 31, 10.1212/WNL.0000000000013038 · DOI · Paper page
- Pop-Busui, 2022, Diagnosis and Treatment of Painful Diabetic Peripheral Neuropathy, 10.2337/db2022-01 · DOI · Paper page
- Tesfaye, 2022, Comparison of amitriptyline supplemented with pregabalin, pregabalin supplemented with amitriptyline, and duloxetine supplemented with pregabalin for the treatment of diabetic peripheral neuropathic pain (OPTION-DM): a multicentre, double-blind, randomised crossover trial, Lancet, 400, 680, 10.1016/S0140-6736(22)01472-6 · DOI · Paper page
- Dworkin, 2007, Symptom profiles differ in patients with neuropathic versus non-neuropathic pain, J Pain, 8, 118, 10.1016/j.jpain.2006.06.005 · DOI
- Barbano, 2004, Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy, Arch Neurol, 61, 914, 10.1001/archneur.61.6.914 · DOI · Paper page
- Briasoulis, 2014, Orthostatic hypotension associated with baroreceptor dysfunction: treatment approaches, J Clin Hypertens (Greenwich), 16, 141, 10.1111/jch.12258 · DOI
- Figueroa, 2010, Preventing and treating orthostatic hypotension: as easy as A, B, C, Cleve Clin J Med, 77, 298, 10.3949/ccjm.77a.09118 · DOI · Paper page
- Jordan, 2019, Management of supine hypertension in patients with neurogenic orthostatic hypotension: scientific statement of the American Autonomic Society, European Federation of Autonomic Societies, and the European Society of Hypertension, J Hypertens, 37, 1541, 10.1097/HJH.0000000000002078 · DOI
- Umpierrez, 2014, Therapy for Diabetes Mellitus and Related Disorders
- Maganti, 2003, Oral erythromycin and symptomatic relief of gastroparesis: a systematic review, Am J Gastroenterol, 98, 259
- McCallum, 2010, Gastric electrical stimulation with Enterra therapy improves symptoms from diabetic gastroparesis in a prospective study, Clin Gastroenterol Hepatol, 8, 947, 10.1016/j.cgh.2010.05.020 · DOI · Paper page
- Schaper, 2020, Practical guidelines on the prevention and management of diabetic foot disease (IWGDF 2019 update), Diabetes Metab Res Rev, 36, e3266, 10.1002/dmrr.3266 · DOI · Paper page
- Reiber, 1999, Causal pathways for incident lower-extremity ulcers in patients with diabetes from two settings, Diabetes Care, 22, 157, 10.2337/diacare.22.1.157 · DOI · Paper page
- Reaney, 2022, Information about foot care provided to people with diabetes with or without their partners: impact on recommended foot care behavior, Appl Psychol Health Well-Being, 14, 465, 10.1111/aphw.12314 · DOI
- Heng, 2020, A collaborative approach in patient education for diabetes foot and wound care: a pragmatic randomised controlled trial, Int Wound J, 17, 1678, 10.1111/iwj.13450 · DOI
- Bus, 2020, Guidelines on the prevention of foot ulcers in persons with diabetes (IWGDF 2019 update), Diabetes Metab Res Rev, 36, e3269, 10.1002/dmrr.3269 · DOI · Paper page
- Goodall, 2020, A systematic review of the impact of foot care education on self efficacy and self care in patients with diabetes, Eur J Vasc Endovasc Surg, 60, 282, 10.1016/j.ejvs.2020.03.053 · DOI
- Yuncken, 2018, People with diabetes do not learn and recall their diabetes foot education: a cohort study, Endocrine, 62, 250, 10.1007/s12020-018-1714-1 · DOI
- Walton, 2021, People living with diabetes are unaware of their foot risk status or why they are referred to a multidisciplinary foot team, J Wound Care, 30, 598, 10.12968/jowc.2021.30.8.598 · DOI
- Bus, 2016, Footwear and offloading interventions to prevent and heal foot ulcers and reduce plantar pressure in patients with diabetes: a systematic review, Diabetes Metab Res Rev, 32, 99, 10.1002/dmrr.2702 · DOI · Paper page
- Rogers, 2011, The Charcot foot in diabetes, Diabetes Care, 34, 2123, 10.2337/dc11-0844 · DOI · Paper page
- Frykberg, 2015, Challenges in the treatment of chronic wounds, Adv Wound Care (New Rochelle), 4, 560, 10.1089/wound.2015.0635 · DOI · Paper page
- Frykberg, 2020, A multinational, multicenter, randomized, double-blinded, placebo-controlled trial to evaluate the efficacy of cyclical topical wound oxygen (TWO2) therapy in the treatment of chronic diabetic foot ulcers: the TWO2 study, Diabetes Care, 43, 616, 10.2337/dc19-0476 · DOI
- Sheehan, 2003, Percent change in wound area of diabetic foot ulcers over a 4-week period is a robust predictor of complete healing in a 12-week prospective trial, Diabetes Care, 26, 1879, 10.2337/diacare.26.6.1879 · DOI · Paper page
- Blume, 2008, Comparison of negative pressure wound therapy using vacuum-assisted closure with advanced moist wound therapy in the treatment of diabetic foot ulcers: a multicenter randomized controlled trial, Diabetes Care, 31, 631, 10.2337/dc07-2196 · DOI · Paper page
- Argenta, 2006, Vacuum-assisted closure: state of clinic art, Plast Reconstr Surg, 117, 127S, 10.1097/01.prs.0000222551.10793.51 · DOI · Paper page
- Santema, 2018, Hyperbaric oxygen therapy in the treatment of ischemic lower- extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial, Diabetes Care, 41, 112, 10.2337/dc17-0654 · DOI · Paper page
- Fedorko, 2016, Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: a prospective, double-blind, randomized controlled clinical trial, Diabetes Care, 39, 392, 10.2337/dc15-2001 · DOI · Paper page
- Lalieu, 2020, Hyperbaric oxygen therapy for nonischemic diabetic ulcers: a systematic review, Wound Repair Regen, 28, 266, 10.1111/wrr.12776 · DOI
- Niederauer, 2018, Continuous diffusion of oxygen improves diabetic foot ulcer healing when compared with a placebo control: a randomised, double-blind, multicentre study, J Wound Care, 27, S30, 10.12968/jowc.2018.27.Sup9.S30 · DOI
- Serena, 2021, Topical oxygen therapy in the treatment of diabetic foot ulcers: a multicentre, open, randomised controlled clinical trial, J Wound Care, 30, S7, 10.12968/jowc.2021.30.Sup5.S7 · DOI
- Sun, 2022, Efficacy and safety of topical oxygen therapy for diabetic foot ulcers: an updated systematic review and meta-analysis, Int Wound J, 19, 2200, 10.1111/iwj.13830 · DOI
- Frykberg, 2021, Topical wound oxygen therapy in the treatment of chronic diabetic foot ulcers, Medicina (Kaunas), 57, 917, 10.3390/medicina57090917 · DOI
- Sethi, 2022, Topical oxygen therapy for healing diabetic foot ulcers: a systematic review and meta-analysis of randomised control trials, Health Sci Rep, 3, 100028
- van Netten, 2016, Prevention of foot ulcers in the at-risk patient with diabetes: a systematic review, Diabetes Metab Res Rev, 32, 84, 10.1002/dmrr.2701 · DOI · Paper page
- Frykberg, 2022, The at-risk diabetic foot: time to focus on prevention, Diabetes Care, 45, e144, 10.2337/dc22-1111 · DOI
Cited by
Diaz, E. A., Seifert, M. L., Gruning, V., Stadnick, N. A., Lugo-Butler, E., Servin, A. N., Rodríguez-Rosales, C. I., Geremia, C., Ramachandra, C., Bhaskaranand, M., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.38114 · Cited by 9
Braffett, B. H., El ghormli, L., Martin, C., White, N. H., Hirsch, I. B., Bantle, A., Carlson, A., Leschek, E., Gubitosi-Klug, R., Soliman, E. Z., et al. (2025) · Cardiovascular Diabetology · doi:10.1186/s12933-025-02856-9 · Cited by 5
“Yet, despite the proven prognostic value and current guideline recommendations for screening [11, 12].”
Diabetic retinopathy treatment cascade and care continuum in the USA: a systematic review
Fu, J. J., Applebaum, S. S., Granados, A., & Nwanyanwu, K. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-117683 · Cited by 1
Metadata
- Authors
- American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Gibbons, C. H., Giurini, J. M., Hilliard, M. E., Johnson, E. L., Khunti, K., Lingvay, I., Matfin, G., McCoy, R. G., Perry, M. L., Pilla, S. J., Polsky, S., Prahalad, P., Pratley, R. E., Segal, A. R., Seley, J. J., Silva, P. S., Stanton, R. C., & Gabbay, R. A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2023-12-11
- Volume
- 47
- Issue
- Supplement_1
- Pages
- S231-S243
- ISSN
- 0149-5992 (ISSN-L)
- OpenAlex
- W4389571995
- Cited by
- 207
- References
- 34
- FWCI
- 34.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.